| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |